These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5386042)

  • 1. [Effects of diet changes and use of dextrothyroxine and chlorphenisate on serum lipids].
    Arteaga A; Cisternas H; Torres MC; Alliende ME
    Rev Med Chil; 1969 May; 97(5):285-90. PubMed ID: 5386042
    [No Abstract]   [Full Text] [Related]  

  • 2. Diet and drugs in the treatment of hyperlipidemias.
    Med Lett Drugs Ther; 1970 May; 12(10):42-4. PubMed ID: 5514225
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of clofibrate and dextrothyroxine singly and in combination on serum lipids.
    Best MM; Duncan CH
    Arch Intern Med; 1966 Aug; 118(2):97-102. PubMed ID: 5329616
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of a new drug (CH 13437) in the treatment of hyperlipemia].
    Arteaga A; Foradori A; Eyzaguirre J; Lira P; Vasquez A; Soto S; Alliende ME; Guzman L
    Rev Med Chil; 1970 Oct; 98(10):689-94. PubMed ID: 4927028
    [No Abstract]   [Full Text] [Related]  

  • 5. Clofibrate and dextrothyroxine in coronary heart diseases. A clinical and biochemical study.
    Bhatia ML; Setty KR; Roy SB
    J Assoc Physicians India; 1971 Feb; 19(2):123-9. PubMed ID: 4934418
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipid lowering agents.
    Br Med J; 1972 Jun; 2(5814):642-3. PubMed ID: 5031693
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypolipidemic agents--newly approved.
    Duncan GG
    Pa Med; 1967 Aug; 70(8):75-6. PubMed ID: 6073724
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of dyslipemias with the association of dx-thyroxine and choleretics].
    Martinelli M; Albini U; Villecco A
    Boll Soc Ital Cardiol; 1970; 15(6):539-43. PubMed ID: 5517650
    [No Abstract]   [Full Text] [Related]  

  • 9. [Medical treatment of hyperlipemia. Indications and modern preparations].
    Frey H
    Tidsskr Nor Laegeforen; 1968 Jan; 88(2):6-8. PubMed ID: 5663311
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate).
    Bergqvist N
    Acta Med Scand; 1970 Mar; 187(3):213-8. PubMed ID: 5444978
    [No Abstract]   [Full Text] [Related]  

  • 11. Diet and drug therapy for hyperlipoproteinemia.
    Maha GE
    Med Times; 1971 Aug; 99(8):49-63 passim. PubMed ID: 5566828
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical trial of C.P.I.B. (clofibrate) in treatment of diabetic hypertriglyceridemia].
    Warembourg H; Jaillard J
    Lille Med; 1968 Jan; 13(1):Suppl:5-8. PubMed ID: 5745605
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of essential hyperlipemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jun; 24(12):184-7. PubMed ID: 5404292
    [No Abstract]   [Full Text] [Related]  

  • 14. Control of biochemical precursors of coronary heart disease.
    Ostrander LD
    Geriatrics; 1969 Dec; 24(12):61-6. PubMed ID: 5353631
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum-lipid reducing principles--possibilities for treatment. 8. Diet and drug treatment].
    Hood B
    Lakartidningen; 1970 Dec; 67():Suppl IV:89+. PubMed ID: 5511956
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serum-lipid reducing principles--possibilities for treatment. 6. Indications for the use of clofibrate].
    Gustafson A
    Lakartidningen; 1970 Dec; 67():Suppl IV:75+. PubMed ID: 5511954
    [No Abstract]   [Full Text] [Related]  

  • 17. The Coronary Drug Project. Initial findings leading to modifications of its research protocol.
    JAMA; 1970 Nov; 214(7):1303-13. PubMed ID: 4320008
    [No Abstract]   [Full Text] [Related]  

  • 18. [Arteriosclerosis--nicotinic acid therapy. 10. Combination therapy in hyperlipemia].
    Hansen PF
    Lakartidningen; 1971 Apr; 68(15):1769-72. PubMed ID: 5577252
    [No Abstract]   [Full Text] [Related]  

  • 19. Peripheral vascular disease improved by clofibrate.
    Exp Med Surg; 1968; 26(4):277-9. PubMed ID: 5736504
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate.
    Nordoy A; Rodset JM
    Acta Med Scand; 1971 May; 189(5):385-9. PubMed ID: 5578488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.